LinkedIn has hired three-time world Sudoku champion Thomas Snyder as its first-ever principal puzzlemaster. Snyder has ...

Generate Biomedicines has completed its IPO, raising an impressive $400 million that makes it the largest listing for a biotech on the Nasdaq so far this year. Incubated by investment group Flagship ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

The GW Ranch project approved on 8,000 windswept acres of West Texas will look like many of the other data centers that have sprung up across the country to support Silicon Valley’s ambitions for ...

Artificial intelligence company Anthropic announced Wednesday that it will ensure consumer electricity costs remain steady as it expands its data center footprint. Subscribe to read this story ad-free ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

A group that monitors the U.S. electricity system warns that grid reliability is “worsening” and blackout risks are rising for millions of people. By Brad Plumer Reporting from Washington The ...